Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at Taro Pharmaceutical Industries TARO is 53.10%. Taro Pharmaceutical's revenue for the same period is $665.00 million.
The trailing-twelve-month operating margin at United Therapeutics UTHR is 41.95%. United Therapeutics' PEG ratio is 1.77.
The trailing-twelve-month operating margin at Endo Health Solutions ENDP is 30.09%. Endo Health had $505.61 million in total cash for the latest quarter.
The trailing-twelve-month operating margin at Cubist Pharmaceuticals CBST is 19.25%. Cubist Pharmaceuticals' ROE for the same period is 10.23%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in